Thyrocare Technologies — 360° view

Thyrocare Technologies, a company in the Healthcare Service Provider industry, reported revenue of ₹271 crore and net profit of ₹15 crore for the September 2026 quarter.

Thyrocare Technologies (NSE: THYROCARE) closed at ₹528.45 on 20 Nov 2026, up 3.9% over the past year. Its market capitalisation is ₹8,421 crore and it trades at 48.1 times earnings.

Share price
₹528.45 (20 Nov 2026)
Market cap
₹8,421 Cr (20 Nov 2026)
P/E
48.07 (20 Nov 2026)
Revenue
₹271 Cr (September 2026 quarter)
Net profit
₹15 Cr (September 2026 quarter)
ROCE
35.4% (FY26)
ROE
28.4% (FY26)
Book value
₹34.8 (FY26)
Dividend yield
1.32% (last 12 months to 20 Nov 2026)
52-week high / low
₹662.00 / ₹342.55 (20 Nov 2026)
1-year return
3.9% (to 20 Nov 2026)
Sector
Healthcare
Industry
Healthcare Service Provider
Symbol
NSE: THYROCARE

Thyrocare Technologies is engaged in the business of healthcare industry and is involved in providing quality diagnostic services at affordable costs to patients, laboratories and hospitals in India.

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.